Objective To correlate existing evaluation tools with clinical information on Duchenne muscular dystrophy (DMD) patients following age and to investigate genetic mutation and its relationship with clinical function. Method Th e medical records of 121 children with DMD who had visited the pediatric rehabilitation clinic from 2006 to 2009 were reviewed. Th e mean patient age was 9.9±3.4 years and all subjects were male. Collected data included Brooke scale, Vignos scale, bilateral shoulder abductor and knee extensor muscles power, passive range of motion (PROM) of ankle dorsi-flexion, angle of scoliosis, peak cough flow (PCF), fractional shortening (FS), genetic abnormalities, and use of steroid. Results The Brooke and Vignos scales were linearly increased with age (Brooke (y 1 ), Vignos (y 2 ), age (x), y 1 =0.345x-1.221, R Brooke 2 =0.435, y 2 =0.813x-3.079, R Vignos 2 =0.558, p<0.001). In relation to the PROM of ankle dorsifl exion, there was a linear decrease in both ankles (right and left R 2 =0.364, 0.372, p<0.001). Muscle power, Cobb angle, PCF, and FS showed diversity in their degrees, irrespective of age. Th e genetic test for dystrophin identifi ed exon deletions in 58.0% (69/119), duplications in 9.2% (11/119), and no deletions or duplications in 32.8% (39/119). Statistically, the genetic abnormalities and use of steroid were not defi nitely associated with functional scale. Conclusion The Brooke scale, Vignos scale and PROM of ankle dorsi-flexion were partially available to assess DMD patients. However, this study demonstrates the limitations of preexisting scales and clinical parameters incomprehensively refl ecting functional changes of DMD patients.
INTRODUCTION
Muscular dystrophy (MD) is a devastating inherited neuromuscular disease characterized by early onset and progressive course. Duchenne muscular dystrophy (DMD) is the most common subtype of MD with an incidence of 1 in 3,500 to 6,000 live male births. 1 Th e DMD is a pattern of X-linked recessive inheritance charac terized by lack of dystrophin, which provides structural stability to the dystroglycan complex, located on the cell membrane within muscle tissues. 2, 3 As a result, progressive proximal
www.e-arm.org muscle weakness usually appears in male children before age 5 years, and eventual gait diffi culty follows. In general, DMD patients increasingly rely on a wheelchair by age 15 years, and death usually occurs before or at 20 years of age. [4] [5] [6] As the disease progresses, most patients present various symptoms including joint contractures and muscle weakness in bilateral limbs, scoliosis, aggravated lumbar lordosis, 7 dilated cardiomyopathy, 8, 9 and dyspnea due to respiratory muscle failure. 10, 11 Th ere are different kinds of treatment options depending on the goal of treatment; steroids, such as Deflazacort for walking and cardiac function, 12, 13 bracing for deformities of joints and spine, and physical or aqua therapies for weakness or poor general condition. 14 However, the aforementioned treatments only slow down the disease progression rather than provide a complete cure. At present, the life expectancy of DMD patients have been extended by the development of medical technology, an increase in rehabilitation facilities, and an increased accessibility of hospital for general medical care. 15 In addition, molecular and genetic therapies, such as exon skipping, mutation-specific treatment using nonsense codon suppressors, and gene therapy using viral and nonviral vectors, have been tried. Effects of these treatments are discussed, and expected to be used for the treatment of DMD patients in near future. [16] [17] [18] There are a few objective functional scales for DMD patients, but these are not commonly used. Brooke scale is an evaluation tool for upper extremity function with limitations for estimating lower extremity function and joint contractures. 19 Vignos scale is a popular evaluation index primarily for lower extremity function, however, the grading is not clear. 19 In addition, according to an increased power wheelchair use led to reduced demand for orthosis, such as knee-ankle-foot orthosis (KAFO), subscales of the Vignos scale need to be revised. In 2006, Lue YJ et al. reported on the development of a muscular dystrophy-specific functional rating scale (MDFRS), 20 which is a comprehensive evaluation tool that takes into account both upper and lower extremities function and contractures in MD. However, respiratory and cardiac functions are diffi cult to check and have rarely been used in the clinical setting. Despite increased life expectancy and new developing treatment techniques, comprehensive and clinical evaluation tools are still lacking. Moreover whether the existing assessment tools accurately reflect the functioning of DMD patients has not reported in detail. In this study, the objective was to correlate clinical information to already existing assessment tools and age. Furthermore, we investigated the genetic mutation in the dystrophin gene and its relationship with function, as well as functional change following Defl azacort use.
MATERIALS AND METHODS

Subjects
Th e medical records of DMD patients between January 2006 and February 2009 at the pediatric rehabilitation clinic were reviewed retrospectively. All 121 subjects were male and had a mean age of 9.85±3.39 years at their fi rst visit (Table 1) . Th e diagnosis of DMD was confi rmed by genetic testing, muscle biopsy, and clinical findings by pediatrician and rehabilitation medicine specialist or previous diagnosis in another hospital. Evaluation exclusion criteria including Brooke scale, Vignos scale, and muscle power were; wearing splint or orthosis due to recent trauma or operation, medical problems (pneumonia that could affect the general condition), and a recently deteriorating condition due to seizures. Patients were also excluded from the study if records related to evaluation were incomplete because of poor cooperation.
Methods
Items refl ecting function and physical condition of DMD patients were selected from the medical records based Table 2 ). The PROM of bilateral ankle dorsi-fl exion was measured in sitting or supine position with knees fl exed to 90 degree by a goniometer with one axis parallel placed at the fi bular shaft and the others at the fifth metatarsal bone. Passive dorsi-flexion range of the ankle was recorded as positive, neutral was recorded as 0, and plantar fl exion contracture of ankle that limits dorsi-flexion was recorded as negative. Muscle power was assessed by hand held dynamometer FGN-50 (NidecShimpo corporation, Kyoto, Japan) at bilateral shoulder abductors and knee extensors referred to reported method by Palmieri et al. 25 Th e shoulder abductor muscle power was examined from the lateral forearm when sitting upright, with the shoulder abducted to a 45 degree angle with the elbow was straight and with the forearm in a pronated position. Th e knee extensor muscle power was examined from the anterior surface of distal shaft just proximal to ankle joint in the sitting position with a 90 degree fl exed position. 19 Cobb angle was the method of measuring kyphosis, and was defined as the angle between a line drawn parallel to superior endplate of the superior end vertebra and a second line drawn along the inferior end plate of the inferior end vertebra by Antero-Posterior view of whole spine on X-ray. Starting with arms at the sides, the patient can abduct the arms in a full circle until they touch above the head 2 Can raise arms above head only by fl exing the elbow (shortening the circumference of the movement) or using accessory muscles 3 Cannot raise hands above head, but can raise an 8-oz glass of water to the mouth 4
Can raise hands to the mouth, but cannot raise an 8-oz glass of water to the mouth 5
Cannot raise hands to the mouth, but can use hands to hold a pen or pick up pennies from the  table  6 Cannot raise hands to the mouth and has no useful function of hands Vignos scale for lower extremity (Fig. 1-B) which demonstrates lower extremity function was correlated relatively with age. Bilateral ankle dorsi-flexion angles showed a decreasing tendency as age increased. R square value for right was 0.364 (n=218, p<0.001, right ankle dorsi-fl exion PROM (y 1 ), age (x), y 1 =−4.535x+35.362) and R 2 for left was 0.372 (n=219, p<0.001, left ankle dorsifl exion PROM (y 2 ), age (x), y 2 =−4.525x+35.568) (Fig. 2) . In other words, as age increased, the more the ankle plantar contracture progressed in DMD. R square value was very low for bilateral shoulder www.e-arm.org (Fig. 3) . There was no correlation between age and clinical indexes (Fig. 4) 
Genetic testing
We reviewed 119 genetic results from 121 patients; records of genetic results were not present for 2 patients. The genetic mutation in 71 subjects (59.7%) was confirmed by MLPA, 22 (18.5%) by mPCR, and 16 (13.4%) by mPCR combined with MLPA. A specific method of genetic test was not recorded in 10 subjects; however, results of genetic mutation were recorded. Genetic abnormality was categorized by exon mutation, such as exon deletion of 67 (58%), duplication of 11 (9.2%), and no deletion or duplication of 39 (32.8%, Table 1 ). Among 39 patients without deletion or duplication, sequence variant was verifi ed at 6 and one patient had a nonsense mutation.
In the 69 patients with deletions, the majority (30 pa 
Functional change ac cording to the use of Defl azacort
Ninety-three (76.9%) patients of 121 used Deflazacort (Table 1) . Th e eff ects of using Defl azacort were analyzed to change the Vignos scale, which was correlated with disease progression in the previous results. Contrary to previous research, patients with Deflazacort were at increased risk of an increasing Vignos scale compared with patients without Deflazacort. This result indirectly suggests that Vignos scale was not aff ected by the use of Deflazacort or was increased by Deflazacort, however, this was not statistically signifi cant (p=0.59).
DISCUSSION
The strength of the study is that it had lots of data collected from many DMD patients and confined subjects to DMD patients instead of covering various kinds of MD, which made homogeneity enhanced. In addition, the study made a comprehensive evaluation of cardiopulmonary function by making good use of the Vignos scale, the Brooke scale, PCF, and FS. In addition, this study is significant in that it objectively examined the relationship between the change in patient function and age by the use of evaluation tools and lots of genetic information.
The limitation of this study is that there is a great deal of missing data and it did not examine the change in patient functions by age, progressively. If there had been no missing data, we could have obtained a result by analyzing values measured according to change in age through Analysis of variance (ANOVA). However, this study could not examine the change in function, as there was missing data and age periods for evaluating function were different. In addition, the study used partial aspects of materials due to diffi culty of grasping general condition of patients as the study was dependent upon retrospective study, which was dependent upon medical records. Besides, the study did not clearly distinguish One of the purposes of this study was to examine whether evaluation tools showed a tendency properly that the functions weaken as the disease progresses and the age increases when functional evaluation tools are actually applied to DMD patients. To this end, the work on choosing items that can reflect the function and clinical status of DMD patients was conducted. Functional evaluation tools and clinical assessment of DMD patients reported by previous research were examined through expert meeting. A total 7 items, including cardiac assessment by adding signifi cant items that were considered necessary and can be easily checked in outpatient clinics were determined. Gowers' sign, in which a patient pushes himself up from his knee with his hand when he stands up after laying face down or sitting on the ground, was considered positive. In cases in which mental retardation (MR) 35 was confi rmed and the case in which MR was not confi rmed under Korean Educational Development Institute-Wechsler Intelligence Scale for Children (KEDI-WISC), and Korean-Child Behavior Checklist (K-CBCL) were distinguished by requesting the test child psychiatrist. Th e relation between Gowers' sign and deteriorating intelligence was not analyzed due to missing data and the diffi culty in comparing according to change in age. Among the total 121 DMD patients, those who showed a positive Gowers' sign were 24, those who showed negative reaction in Gowers' sign were 9; and those who did not show clear reaction were 3 and those who did not have data were 85. There were 17 patients with MR; patients who did not show MR were 48 and 56 patients did not have data.
It was found that among tools that evaluate DMD patients, Vignos scale showed the pattern that increases linearly according to the change in age most signifi cantly. Th is fi nding means that the reduction in function appears linear in proportion to the increase in age and it is expected that Vignos scale will help predict the change in functions of DMD patients. It was found that the Brooke scale increased linearly in proportion to the increase in age, whereas PROM of bilateral ankle dorsi-flexion decreased. It is expected that these fi ndings are useful in inferring the change in functions by age.
It is reported that dilated cardiomyopathy is common in DMD patients, in particular those DMD patients who have diffi culty in walking due to severe DMD. 10 However, this study found that FS did not decrease in proportion to an increase in age. This result may be attributed to the fact that most of the subjects in this study were in relatively good condition, which prevented the deterioration in heart function from clearly being shown. As individual difference is large in FS, a significant result can be obtained when the change in patients is analyzed progressively; however, because the result of echocardiography used in this study was obtained by comparing the results at a certain point of subjects which prevented the deterioration of function being identifi ed. It is estimated that the fact that this study did not evaluate the functioning of DMD patients by using the history of taking heart disease related medicines and B-type natriuretic peptide (BNP), 32 which is commonly used as an indicator of heart function and limited the evaluation of heart function. It was also found that bilateral shoulder abductor and knee extensor muscles power, Cobb angle and PCF did not show a linear increase or a linear decrease in proportion to age. It is estimated that the result may be attributed to the fact that muscular strength of DMD patients increased in the early stage, but decreases as DMD progresses and scoliosis develops in only some parts and worsens sharply in proportion to age. Dystrophin gene is located at Xp21.2 and large gene consisting of 79 exons with the size of 2.4 Mb. Deletion is most common in the dystrophin gene mutation and the generation of duplication was found in 5-10% of the patients 36 and variation, such as point mutations, microdeletions and microinsertions were found in 20-30% of the patients. 37 Exon deletion, which is most common in dystrophin gene mutation, was found in 58.0% (69/119) of the patients with similar findings in the results of previous research (55-65%). It was found that duplication was 9.2% (11/119), which coincides with result of previous studies. 36, 38 The site of gene deletion generation is called a 'hot spot' and the hot spot is the fi rst 20 exons located within 500 kb from the end of 5' and is located between exon 44 and exon 55 located within 1,200 kb from fi rst exon. 39 It is reported that the deletion frequency is highest in the middle part of 1,200 kb. 33, 36 Th is study revealed that greatest dystrophin gene deletion www.e-arm.org was found exon 50 that is located between exon 44 and 55 and exon 46, exon 47, and exon 49 was highly frequent deletion site. Like DMD, BMD which is somewhat slight in symptoms can be generated by dystrophin gene deletion. If the deletion site moves the translational reading frame of mRNA, transcription ends in early stage in "out of frame deletion" and dystrophin protein is not formed and severe DMD is revealed. On the contrary, despite deletion, if the translational reading frame is preserved, abnormal protein or protein with small molecular mass generates in "in frame deletion" and slight BMD becomes revealed. 40 Two tests used by our hospital are known as the method that can accurately identify deletion and duplication in the dystrophin gene, but as mPCR selectively examines those exons in which deletion is common, mPCR is not enough to accurately identify gene deletion or duplication. Thus, our hospital reexamines patients by using MLPA though medical checkup and was done through mPCR in this case; whether there is deletion or duplication that is revealed through MLPA is examined. Statistical analysis was conducted through gene diagnosis after checking whether there was something remarkable in the results reported by the laboratory medicine department of our hospital. 33, 41 However, in MLPA implemented, the total genetic sequencing of dystrophin was not done and therefore it was impossible to gain information on in frame deletion and out of frame deletion. This study examined whether there is difference by comparing the Vignos and Brooke scales, PROM of bilateral ankle dorsi-flexion of patients who had single deletion and 4 or more deletions among deletions shown between exon 44 and 55. Comparisons were made under the assumption that the more exons deletion in DMD patients, the worse the function in DMD patients but statistical significance was not found except Brooke scale. In the case that score was recorded and the number of subjects was small, Brooke scale shows good function (1 or 2 point) and the diff erence in age was not corrected, it was difficult to interpret that there was a difference in functioning. Further research is needed because functional scale showed a tendency of becoming deteriorated when there is 4 or more exon deletions. Th e tools that can evaluate DMD patients comprehensively and objectively are needed for this type of further research and if such tools are developed and used, the correlation functions evaluated in the clinical setting and the result of gene diagnosis can be fully explained.
The influence of steroids, which has been reported to delay natural progress of the disease, has on walking of DMD patients was examined, 11, 12 and the result of this study was different from the report mentioned above. This difference may be attributed to the errors that Defl azacort was used at the time when walking became not easy and drug therapy was given to the patients who showed deterioration of functions. This result is considered as limit that is shown in analysis which uses retrospective data and estimated as indication bias. Introducing a system that measures severity of the disease or introducing propensity scoring matching (PSM) that can evaluate the relation between various factors and medical treatments will help overcome indication bias. Th e result of this study revealed that existing functional evaluation tools have limits in making a comprehensive evaluation of the functions of DMD patients. The tools such as Vignos scale and Brooke scale refl ect the function of lower extremities and upper extremities separately and therefore they are not enough to check the change in comprehensive functions of DMD patients. Th e MDFRS has weakness that it requires lots of time and effort to apply it patients. Functional evaluation tools that can reflect the condition of DMD patients comprehensively and objectively and are easy to use have not been reported yet. This study showed the limit existing functional evaluation tools have and the development of new functional evaluation tools that can check clinical eff ect of medical treatment at this stage new remedies make appearances is needed.
CONCLUSION
Th e abilities of the Vignos scale for refl ecting functional deterioration and the Brooke scale for decreasing ankle PROM as age increases in DMD patients were confi rmed in this study. Also the results of exon deletion and duplication in 69 (58.0%) and 11 (9.2%) patients, respectively, resemble that of previous reports on DMD patients. Additionally, despite the statistical signifi cance on the Brooke scale in those with single and 4 and more exons deletion at the 'hot spot' between exon 44 and 55, www.e-arm.org supporting evidence for its clinical significance is still lacking. Differences in the Vignos scale and the PROM of bilateral ankle dorsi-flexion were not statistically signifi cant.
The study confirmed the limitation of currently used functional evaluation tools in reflecting functional deterioration according to age and only evaluating upper or lower extremity function in DMD patients. A recent increase in life expectancy of DMD patients and large clinical trials on new treatment methods require new functional evaluation tools for DMD patients that can reflect the clinical characteristics and quantitatively judge the treatment eff ect, as well as accurately represent the functional deterioration as the disease progresses and integrated overall function of the DMD patients, to be developed.
